![Albert Tsai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Albert Tsai is Chief Medical Officer at VivaVision Biotech (Zhejiang) Co., Ltd. since 2025.
Formerly, Dr. Tsai was Vice President at PPD, Inc. from 2019 to 2021 and Chief Medical Officer at Zhaoke Ophthalmology Ltd. Education includes an MBA from the University of Southern California and a doctorate from Northwestern University.
Aktiva positioner av Albert Tsai
| Företag | Position | Start |
|---|
Tidigare kända positioner av Albert Tsai
| Företag | Position | Slut |
|---|---|---|
| PPD, INC. | Företagsledare/Principal | 2021-01-01 |
| ZHAOKE OPHTHALMOLOGY LIMITED | Teknisk/Vetenskaplig/F&U Direktör | - |
Albert Tsais utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
14
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PPD, Inc.
 PPD, Inc. BiotechnologyHealth Technology Engages in research and development of biopharmaceutical industry | Health Technology |
Zhaoke Ophthalmology Ltd.
 Zhaoke Ophthalmology Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies ophthalmic topical drugs | Health Technology |
